| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/18/2008 | US20080226612 Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | CA2681118A1 Amide derivatives as calcium channel blockers |
| 09/18/2008 | CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| 09/18/2008 | CA2677713A1 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 09/17/2008 | EP1970386A2 Hybrid immunoglobulins |
| 09/17/2008 | EP1970370A1 Amorphous form of 1,2-dihydropyridine compound |
| 09/17/2008 | EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism |
| 09/17/2008 | EP1970070A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/17/2008 | EP1970050A1 Intravenous emulsion of butylbenzene phthalein and its application |
| 09/17/2008 | EP1969368A2 Potentiation of apoptosis by monoclonal antibodies |
| 09/17/2008 | EP1968961A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 09/17/2008 | EP1968956A2 Calcium channel antagonists |
| 09/17/2008 | EP1968941A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 09/17/2008 | EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 09/17/2008 | EP1968605A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 09/17/2008 | EP1968593A2 Pharmaceutical composition comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 09/17/2008 | EP1968576A1 Mif inhibitors |
| 09/17/2008 | EP1968567A1 Omega 3 fatty acid formulations |
| 09/17/2008 | EP1968563A2 Treatment methods using triaryl methane compounds |
| 09/17/2008 | EP1968561A2 Treatment of renal disorders, diabetic nephropathy and dyslipidemias |
| 09/17/2008 | EP1968546A2 Stables s-nitrosothiol formulations |
| 09/17/2008 | EP1411968B1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | EP1379557B1 Use of cd25 binding molecules in steroid-resistant patients |
| 09/17/2008 | EP1307450B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 09/17/2008 | EP1305334B1 Urocortin proteins and uses thereof |
| 09/17/2008 | EP1245676B1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof |
| 09/17/2008 | EP1202736B1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/17/2008 | EP0712303B2 Skin patches comprising testosterone and optionally estrogen |
| 09/17/2008 | CN101268096A Y2 selective receptor agonists for therapeutic interventions |
| 09/17/2008 | CN101268074A 5-amino-4-hydroxy-7- (imidazo [1,2-A] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 09/17/2008 | CN101268065A Process for preparing an angiotensin II receptor antagonist |
| 09/17/2008 | CN101268054A Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, pharmaceutical compositions and therapeutic use |
| 09/17/2008 | CN101268047A Crystalline and amorphous sodium atorvastatin |
| 09/17/2008 | CN101267823A Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 09/17/2008 | CN101265484A Method for constructing pacing channel gene hypotype HCN2 recombination slow virus vector |
| 09/17/2008 | CN101265299A Biologically active peptides from functional domains of bactericidal permeability-increasing protein and uses thereof |
| 09/17/2008 | CN101265292A Polypeptides substances, preparing method and use thereof |
| 09/17/2008 | CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/17/2008 | CN101265250A Substituted flavonoids and preparation method, application and pharmaceutical composition thereof |
| 09/17/2008 | CN101265226A Compounds and methods for delivery of prostacyclin analogs |
| 09/17/2008 | CN101264319A Preparation of exenatide freeze-drying preparation |
| 09/17/2008 | CN101264312A Medicaments for treating dizziness |
| 09/17/2008 | CN101264290A Orally-administered Chinese medicine for treating hypertension and preparation thereof |
| 09/17/2008 | CN101264259A Chinese medicinal composition for treating rheumatic heart disease and preparation thereof |
| 09/17/2008 | CN101264228A Chinese medicinal composition for treating hypertension |
| 09/17/2008 | CN101264227A Quality control method of í«pingfeng shengmaií» capsule |
| 09/17/2008 | CN101264224A Medicine for treating hemorrhoid |
| 09/17/2008 | CN101264213A Externally-applied medicine for treating hemorrhoid |
| 09/17/2008 | CN101264199A Medicaments for treating ischemic apoplexy sequela |
| 09/17/2008 | CN101264189A Cardiac disease rehabilitation proprietary Chinese medicine |
| 09/17/2008 | CN101264183A Proprietary Chinese medicine for reducing blood pressure and its manufacturing method |
| 09/17/2008 | CN101264180A Application of downy grape and its extraction in preparing antithrombotic medicaments |
| 09/17/2008 | CN101264176A Sangju neck protective pillow and manufacturing method thereof |
| 09/17/2008 | CN101264174A Anti-hypertensive capsule and preparation technique thereof |
| 09/17/2008 | CN101264167A Compound eyesight-improving Chinese medicine |
| 09/17/2008 | CN101264158A Application of Chinese medicine composing prescription in preparing medicaments for treating metabolic syndrome |
| 09/17/2008 | CN101264157A Traditional Chinese medicine for treating high blood pressure |
| 09/17/2008 | CN101264155A Medicine for treatment of piles and preparation method thereof |
| 09/17/2008 | CN101264150A Chinese medicinal composition containing radix astragali and preparation thereof |
| 09/17/2008 | CN101264145A Chinese medicine capsule for treating cardiovascular and cerebrovascular diseases and manufacturing method thereof |
| 09/17/2008 | CN101264133A Externally-applied medicine for treating hemorrhoid |
| 09/17/2008 | CN101264132A Application of compound red sage root tablet in preparing medicine for treating aspirin resistance cardiovascular disease |
| 09/17/2008 | CN101264129A Sugar-free heart-supplementing dracocephali moldavica granula |
| 09/17/2008 | CN101264127A Sophora alopecuroids total alkaloid powder injection and preparation thereof |
| 09/17/2008 | CN101264124A Natural medicine colonic capsules for treating hemorrhoidal disease |
| 09/17/2008 | CN101264123A Natural medicine dropping pills for treating hemorrhoidal disease |
| 09/17/2008 | CN101264120A Modern Chinese medicine decoction pieces, barrenwort flavonol glycosides decoction pieces and preparation thereof |
| 09/17/2008 | CN101264118A Preparation of cirsium japonicum root powder preparation and uses thereof |
| 09/17/2008 | CN101264112A Ligusticum dhuanxiong oil micro-emulsion and preparation thereof |
| 09/17/2008 | CN101264104A Calf serum de-protein injection and producing method thereof |
| 09/17/2008 | CN101264077A Lignans and its use for preparing antiphlogistic antiendotoxin medicaments |
| 09/17/2008 | CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264066A Rutin osmotic pump preparations and preparation thereof |
| 09/17/2008 | CN101264060A Super-critical rapid expansion preparation for water-soluble nano cozymase Q10 powder |
| 09/17/2008 | CN101264051A Modified release pharmaceutical formulation |
| 09/17/2008 | CN100418977C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 09/17/2008 | CN100418968C Pirazino(aza)indole derivatives |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/17/2008 | CN100418965C Imidazopyridine derivatives |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/17/2008 | CN100418545C Chinese medicine composition for treating cardiovascular disease and preparation thereof |
| 09/17/2008 | CN100418542C Hemorrhoids-treating Chinese traditional medicine |
| 09/17/2008 | CN100418535C Aescin medicine composition and its prepn process and use |
| 09/17/2008 | CN100418534C Traditional Chinese medicine active part compound preparation for curing cardiac and cerebral vascular diseases and its preparing method |
| 09/17/2008 | CN100418531C Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 09/17/2008 | CN100418526C Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 09/17/2008 | CN100418522C High-dose hydroxy safflower yellow A or its medically-acceptable salt application for preparing medicine for cerebral apoplexy induced from being ischemic |
| 09/17/2008 | CN100418512C 'Shengmai' infusion and its preparation process |
| 09/17/2008 | CN100418430C Biological health tea |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425571 synergistic admnistration of a weight-loss promoting anticonvulsant and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 09/16/2008 | US7425568 Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |